X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CA-A CANCER JOURNAL FOR CLINICIANS

期刊標題檢索 CA-CANCER J CLI 最新評論: Which hospital do you recommend? ? (2024-01-05)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CA-A CANCER JOURNAL FOR CLINICIANS]您好,您是該頁面的第 163238 位訪客。

期刊簡介
期刊名稱CA-A CANCER JOURNAL FOR CLINICIANS CA-A CANCER JOURNAL FOR CLINICIANS
LetPub Score
9.6
51 ratings
Rate

Reputation
9.9

Influence
9.4

Speed
9.1

期刊簡稱CA-CANCER J CLIN
ISSN0007-9235
E-ISSN1542-4863
h-index144
CiteScore
CiteScoreSJRSNIPCiteScore Rank
873.20106.094167.948
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q11 / 404
Category: Medicine
Subcategory: Hematology
Q11 / 137

自引率 (2023-2024)0.10%自引率趨勢
掲載範囲
CA provides cancer care professionals with up-to-date information on all aspects of cancer diagnosis, treatment, and prevention. The journal focuses on keeping physicians and healthcare professionals informed by providing scientific and educational information in the form of comprehensive review articles and online continuing education activities on important cancer topics and issues that are important to cancer care, along with publishing the latest cancer guidelines and statistical articles from the American Cancer Society.
官方網站http://onlinelibrary.wiley.com/journal/10.3322/(ISSN)1542-4863
在線稿件提交https://mc.manuscriptcentral.com/ca
開放訪問No
出版商Wiley-Blackwell
主題領域医学
出版國/地區UNITED STATES
發行頻率隔月刊行
創刊年1950
每年文章數25每年文章數趨勢
黃金OA百分比92.68%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ11/322
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0007-9235%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 1.0 month(s)
競爭力 *來自作者的數據: About 50%
參考鏈接
相關期刊 【CA-A CANCER JOURNAL FOR CLINICIANS】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    CLINICAL CANCER RESEARCHH-index: 292

    CiteScore: 20.10
    學科內最受檢索的期刊 頁面查看次數
    CANCER LETTERS326090
    CANCER RESEARCH310903
    BMC CANCER242777
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH197870
    INTERNATIONAL JOURNAL OF CANCER188162
    Asian Pacific Journal of Cancer Prevention184121
    CLINICAL CANCER RESEARCH180931
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY171549
    ONCOLOGY REPORTS171142
    CANCER148296
  •  

    CA-A CANCER JOURNAL FOR CLINICIANS CA-A CANCER JOURNAL FOR CLINICIANS
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)
  [CA-A CANCER JOURNAL FOR CLINICIANS] 的評論撰寫評論
作者: Gale Priestley


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-05 17:17:42 評論於
Which hospital do you recommend? ?
(0) 讚! | Gale Priestley

作者: 是志丹吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-29 19:59:52 評論於
Review speed: 3.0 | Submission acceptance rate: 5.0
Main research directions: Epidemiology; Oncology; Cancer
Experience sharing: 254.7 points, impressive!
(0) 讚! | 是志丹吖

作者: 是志丹吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-29 17:14:06 評論於
Impossible. Scored 254.7 points this year
(0) 讚! | 是志丹吖

作者: 可口可乐VS百事


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-28 16:24:00 評論於
Compared to the IF of top journals and the previous year, it has been significantly reduced. Many journal's IF has also dropped this year. What are the reasons behind this? In 2020, the worldwide publication volume for the four categories of SCI was approximately 2.6 million, and it is expected to be around 3 million in 2021 and 2022.
(0) 讚! | 可口可乐VS百事

作者: xianshanliu


領域: 医学
審稿時間: 12.0 month(s)
結果: 修改後接受


撰寫評論

2023-05-24 18:55:40 評論於
Apart from being slightly slower, everything else feels fine. Currently, I am striving for the "Chang Jiang Scholars Program" and the "He Liang He Li Foundation Award." Please discuss more about it. Thank you.
(0) 讚! | xianshanliu

作者: 小娄


領域: 医学
審稿時間: 3.0 month(s)
結果: 直接被接受


撰寫評論

2023-05-17 18:58:02 評論於
Hired and ready to strive for the position of academician.
(0) 讚! | 小娄

作者: 周公旦


領域: 医学
審稿時間: 2.0 month(s)
結果: 拒稿


撰寫評論

2023-03-27 11:30:39 評論於
This journal probably needs to go to the Syrian battlefield to find tens of thousands of cancer-stricken human subjects in order to draw a bunch of conclusions.
(0) 讚! | 周公旦

作者: wangyanyuchuan


領域: 医学
審稿時間: 1.0 month(s)
結果: 直接被接受


撰寫評論

2022-11-08 21:02:44 評論於
I submitted an article in my spare time and accidentally got it accepted. The review process was very efficient, and it was completed within a week. I'm not sure if publishing in this journal fulfills the graduation requirements.
(3) 讚! | wangyanyuchuan

作者: xingyuan


領域: 医学
審稿時間: 1.0 month(s)
結果: 直接被接受


撰寫評論

2022-07-18 21:57:11 評論於
Not bad, not bad, very fast.
(0) 讚! | xingyuan

作者: 星子总在闪


領域: 医学
審稿時間: 2.0 month(s)
結果: 直接被接受


撰寫評論

2022-07-04 17:06:04 評論於
Currently, the Nobel Prize has not been received.
(0) 讚! | 星子总在闪

作者: 八卦采亦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-03 15:15:11 評論於
Does this magazine accept fan mail?
(0) 讚! | 八卦采亦

作者: hjthjt


領域: 医学
審稿時間: 1.0 month(s)
結果: 直接被接受


撰寫評論

2022-04-24 09:30:52 評論於
The difficulty is okay, and the reviewer's comments are very fair. It was accepted after one month, and currently, I am preparing to compete for the Nobel Prize.
(67) 讚! | hjthjt

作者: tanker


領域: 工程技术
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-07 13:39:29 評論於
The opportunity feels unlikely, but let's make a note of it. 
Yutao Wang, Co-Editor-in-Chief 
Submission: April 5, 2022 
With editor: April 7, 2022
(2) 讚! | tanker

作者: 茂勋桑


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-01-07 21:48:53 評論於
Our department rewards 300 thousand for a score of 30 points, so it is possible that rewarding 5000 thousand may cost even more
(0) 讚! | 茂勋桑

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 19:56:51 評論於
References should be within the last 5 years whenever possible. For original and fundamental research findings, older papers may be cited
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 13:23:15 評論於
Before conducting your research, you should conduct a comprehensive literature search and read review articles relevant to the field
(0) 讚! | 维尔娜菲茨杰拉德

作者: 修然小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 18:12:45 評論於
How to comprehensively include important research in the introduction?
(0) 讚! | 修然小公主

作者: 陶宜三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 10:06:00 評論於
Can very old articles be cited in an introduction?
(0) 讚! | 陶宜三岁啦

作者: 邻家飞跃


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-07 21:29:07 評論於
Currently there are only one or two people who can publish this journal domestically, such as the cancer epidemiological statistics in China
(0) 讚! | 邻家飞跃

作者: 邻家飞跃


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-09-07 17:26:24 評論於
Does it matter if you win 2 million on this one? The academicians are here to learn from you
(0) 讚! | 邻家飞跃

作者: 仲夏嘉祯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-30 08:22:28 評論於
Taizhou Municipal People's Hospital in Jiangsu Province, come on!
(0) 讚! | 仲夏嘉祯

作者: 不灭含海


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-27 14:20:46 評論於
Looking for a hospital sign, longing for a job opportunity
(0) 讚! | 不灭含海

作者: SSSSchwein


領域: 医学
審稿時間: 1.0 month(s)
結果: 直接被接受


撰寫評論

2021-06-30 19:06:40 評論於
Invitation to submit an article, accepted within a week, very good.
(4) 讚! | SSSSchwein

作者: 仲夏嘉祯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-12-26 19:01:55 評論於
It seems that the research strength of your hospital is quite good. More than 10 points only get one point for 10,000. Our hospital gets one point for 15,000. Haha
(0) 讚! | 仲夏嘉祯

作者: 王慎思


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2020-08-17 19:57:37 評論於
The experts are very professional, and they returned their opinions one month after the submission. It was accepted. Now I’m participating in the selection of Academicians.

(20) 讚! | 王慎思

首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)

開始撰寫 [CA-A CANCER JOURNAL FOR CLINICIANS] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*